Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma.
Alden SL, Lim M, Kao C, Shu D, Singal AG, Noonan A, Griffith P, Baretti M, Ho WJ, Kamel I, Yarchoan M, Hsiehchen D.
Alden SL, et al.
Cancer Res Commun. 2023 Jul 20;3(7):1312-1317. doi: 10.1158/2767-9764.CRC-23-0072. eCollection 2023 Jul.
Cancer Res Commun. 2023.
PMID: 37484200
Free PMC article.